CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation

NCT00246129 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

123

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation
Kidney Diseases
Kidney Failure

Interventions

DRUG: Campath
DRUG: Daclizumab

Sponsor

EMagnusson